Dr. Agarwal's Eye (DRAGARWQ) | Stock Overview & Key Data
Dr. Agarwal's Eye Performance Comparison
Stock Range
Today's Range
Low: ₹4,407.00
High: ₹4,519.00
on August 18, 2025
52 Week Range
Low: ₹3,500.00
High: ₹7,300.00
on February 12, 2025
on January 3, 2025
All-Time High: ₹7,300.00 on December 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR21.2B
EPS
122.87
P/E Ratio (TTM)
36.63
Forward P/E
463.05
P/B Ratio
10.09
PEG Ratio
1.64
Div. Yield
0.11%
ROE
26.07%
Beta
-0.347
Debt to Equity
158.94
Financial Highlights
Profitability
Gross Margin
58.67%
Operating Margin
22.71%
Profit Margin
13.96%
Returns and Earnings
Return on Assets (TTM)
8.91%
Return on Equity (TTM)
26.07%
EBITDA
INR1.3B
Net Income (TTM)
INR578.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR880.96
Quarterly Revenue Growth (YoY)
16.90%
Quarterly Earnings Growth (YoY)
22.30%
Dividend Information
Last 12-Month Dividend
₹5.00
Current Dividend Yield
0.11%
3-Year Average Dividend Yield
0.12%
3-Year Average Annual Dividend
₹4.50
3-Year Total Dividends
₹13.50
Ex-Dividend Date
November 8, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye DRAGARWQ | 21.15B Small-cap | 3.11% | 1.38% | 8.24% | 10.72% | -30.48% | 13.88% | 469.51% | 1,862.42% |
| Max Healthcare MAXHEALTH | 1.19T Large-cap | -3.57% | -2.31% | 3.75% | 21.63% | 7.12% | 37.91% | 222.13% | 992.35% |
| Apollo Hospitals APOLLOHOSP | 1.12T Large-cap | 9.09% | 8.33% | 13.08% | 24.73% | 6.13% | 16.97% | 89.14% | 366.26% |
| Indraprastha Medical INDRAMEDCO | 41.83B Small-cap | -1.11% | -7.77% | 11.51% | 16.05% | -15.77% | 37.85% | 571.03% | 662.41% |
| Shalby SHALBY | 21.86B Small-cap | -1.22% | 10.72% | 6.94% | 0.48% | -12.09% | -23.54% | 60.19% | 132.49% |
| GPT Healthcare GPTHEALTH | 13.20B Small-cap | -0.96% | -6.30% | 1.51% | 11.75% | -12.17% | -5.66% | -16.08% | -16.08% |
Ownership & Short Interest
Insider Ownership
77.80%
Institutional Ownership
1.81%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
1K
Average 90-Day Volume
1K
Dr. Agarwal's Eye Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Dr. Agarwal's Eye would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is DRAGARWQ's 52-week high and low?
- In the last 52 weeks, Dr. Agarwal's Eye reached a high of ₹7,300.00 (on January 3, 2025) and a low of ₹3,500.00 (on February 12, 2025).
- What is the market cap and P/E ratio for DRAGARWQ?
- Curious about Dr. Agarwal's Eye's size and valuation? Its market capitalization stands at 21.15B. When it comes to valuation, the P/E ratio (trailing twelve months) is 36.63, and the forward P/E (looking ahead) is 463.05.
- Does DRAGARWQ pay dividends? If so, what's the yield?
- Yes, Dr. Agarwal's Eye is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.11%, and the company has paid an average of ₹4.50 per share annually over the past 3 years.
- Who are Dr. Agarwal's Eye's main competitors or similar companies to consider before investing?
When looking at Dr. Agarwal's Eye, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Max Healthcare
MAXHEALTH1.19T Healthcare Medical Care Facilities 37.91% 222.13% Apollo Hospitals
APOLLOHOSP1.12T Healthcare Medical Care Facilities 16.97% 89.14% Indraprastha Medical
INDRAMEDCO41.83B Healthcare Medical Care Facilities 37.85% 571.03% Shalby
SHALBY21.86B Healthcare Medical Care Facilities -23.54% 60.19% GPT Healthcare
GPTHEALTH13.20B Healthcare Medical Care Facilities -5.66% -16.08% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Dr. Agarwal's Eye Hospital Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Dr. Agarwal's Eye's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 26.07%, the Debt to Equity ratio from the most recent quarter is 158.94, and its Gross Profit Margin stands at 58.67%.
- What is the recent revenue and earnings growth for DRAGARWQ?
- Looking at Dr. Agarwal's Eye's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.90%, and quarterly earnings saw a YoY growth of 22.30%.
- How much of DRAGARWQ stock is held by insiders and institutions?
- Wondering who owns Dr. Agarwal's Eye stock? Company insiders (like executives and directors) hold about 77.80% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.81%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.